Cancer Treatment-Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cance
Publication Date: July 1, 2020
Last Updated: March 14, 2022
Recommendations
Pharmacologic recommendations for women with breast cancer
For women with breast cancer who are experiencing drug- or surgery-induced hot flashes, the ONS Guidelines panel suggests using venlafaxine, paroxetine, or clonidine rather than no treatment for the management of symptoms or
- The panel suggests using sertraline, fluoxetine, escitalopram, or duloxetine rather than no treatment for the management of symptoms.a
( Conditional , )7037
Among these pharmaceuticals, the panel suggests using venlafaxine, paroxetine, or clonidine rather than sertraline, fluoxetine, escitalopram, or duloxetine for the management of symptoms.a
( Conditional , Very low)7037
Among venlafaxine, paroxetine, or clonidine, the panel suggests using venlafaxine or paroxetine rather than clonidine for the management of symptoms.a
( Conditional , Low)7037
Remarks: Patients who have not responded to treatment with venlafaxine or paroxetine may wish to try clonidine to manage hot flash symptoms. Patients who have not responded to venlafaxine, paroxetine, or clonidine may wish to try these antidepressants: sertraline, fluoxetine, escitalopram, or duloxetine.a
Title
Cancer Treatment-Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer